Loading…

Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer

Introduction: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer. Methods: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping...

Full description

Saved in:
Bibliographic Details
Published in:Technology in cancer research & treatment 2020, Vol.19, p.1533033820943244-1533033820943244
Main Authors: Yang, Gang, Yang, Yuxia, Ma, Xin, Huang, Lijun, Li, Wenbin, Song, Xuejuan, Zhang, Huiqin, Liu, Wenwen, Lu, Juanjuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923
cites cdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923
container_end_page 1533033820943244
container_issue
container_start_page 1533033820943244
container_title Technology in cancer research & treatment
container_volume 19
creator Yang, Gang
Yang, Yuxia
Ma, Xin
Huang, Lijun
Li, Wenbin
Song, Xuejuan
Zhang, Huiqin
Liu, Wenwen
Lu, Juanjuan
description Introduction: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer. Methods: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology. Results: There were no significant differences in gender and drinking among the 3 groups (P > .05). There were significant differences among the 3 groups in both age-group ≤60 and >60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P > .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA. Conclusion: Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer.
doi_str_mv 10.1177/1533033820943244
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0bc18e2090a34f7f874869168afd967f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1533033820943244</sage_id><doaj_id>oai_doaj_org_article_0bc18e2090a34f7f874869168afd967f</doaj_id><sourcerecordid>2435531607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</originalsourceid><addsrcrecordid>eNp1kdtrFDEUxoMo9qLvPknAF1-m5n55EcrQ1paFFlF8DJlMsptlZrIms4X-92bdutqCTwlfvvM7J-cD4B1GZxhL-QlzShGliiDNKGHsBTjeSc1Oe3m4M3EETkpZI0SEoPg1OKJEYcKRPgY356UkF-0c0wRTgBdf25bDKz_5OTp4l4aHMeXNKpaxwB9xXsE25rxKJRZopx4u4r3PsLWT8_kNeBXsUPzbx_MUfL-8-NZ-aRa3V9ft-aJxnKi5CX2PGWKKYqocY0GToFVQQfcOBcWYZQIToQkPQXW-k07pnlvOsXSk45rQU3C95_bJrs0mx9HmB5NsNL-FlJfG5jr94A3qHFa-bgdZyoIMSjIlNBbKhl4LGSrr85612Xaj752f5myHJ9CnL1NcmWW6N5IxJAmugI-PgJx-bn2ZzRiL88NgJ5-2xRBGOadYIFmtH55Z12mbp7oqQ7hENR3FWXWhvcvlVEr24TAMRmYXunkeei15_-8nDgV_Uq6GZm8odun_dv0v8BcIcrHO</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570002854</pqid></control><display><type>article</type><title>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</title><source>Open Access: PubMed Central</source><source>SAGE Open Access</source><source>Publicly Available Content (ProQuest)</source><creator>Yang, Gang ; Yang, Yuxia ; Ma, Xin ; Huang, Lijun ; Li, Wenbin ; Song, Xuejuan ; Zhang, Huiqin ; Liu, Wenwen ; Lu, Juanjuan</creator><creatorcontrib>Yang, Gang ; Yang, Yuxia ; Ma, Xin ; Huang, Lijun ; Li, Wenbin ; Song, Xuejuan ; Zhang, Huiqin ; Liu, Wenwen ; Lu, Juanjuan</creatorcontrib><description>Introduction: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer. Methods: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology. Results: There were no significant differences in gender and drinking among the 3 groups (P &gt; .05). There were significant differences among the 3 groups in both age-group ≤60 and &gt;60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P &gt; .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA. Conclusion: Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer.</description><identifier>ISSN: 1533-0346</identifier><identifier>EISSN: 1533-0338</identifier><identifier>DOI: 10.1177/1533033820943244</identifier><identifier>PMID: 32812509</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Age ; Cirrhosis ; Gene polymorphism ; Genotype &amp; phenotype ; Genotyping ; Liver cancer ; Liver cirrhosis ; Original</subject><ispartof>Technology in cancer research &amp; treatment, 2020, Vol.19, p.1533033820943244-1533033820943244</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020 2020 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</citedby><cites>FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</cites><orcidid>0000-0001-8446-6382</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440721/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2570002854?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,4012,21953,25740,27840,27910,27911,27912,36999,37000,44577,44932,45320,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32812509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Gang</creatorcontrib><creatorcontrib>Yang, Yuxia</creatorcontrib><creatorcontrib>Ma, Xin</creatorcontrib><creatorcontrib>Huang, Lijun</creatorcontrib><creatorcontrib>Li, Wenbin</creatorcontrib><creatorcontrib>Song, Xuejuan</creatorcontrib><creatorcontrib>Zhang, Huiqin</creatorcontrib><creatorcontrib>Liu, Wenwen</creatorcontrib><creatorcontrib>Lu, Juanjuan</creatorcontrib><title>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</title><title>Technology in cancer research &amp; treatment</title><addtitle>Technol Cancer Res Treat</addtitle><description>Introduction: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer. Methods: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology. Results: There were no significant differences in gender and drinking among the 3 groups (P &gt; .05). There were significant differences among the 3 groups in both age-group ≤60 and &gt;60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P &gt; .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA. Conclusion: Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer.</description><subject>Age</subject><subject>Cirrhosis</subject><subject>Gene polymorphism</subject><subject>Genotype &amp; phenotype</subject><subject>Genotyping</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Original</subject><issn>1533-0346</issn><issn>1533-0338</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kdtrFDEUxoMo9qLvPknAF1-m5n55EcrQ1paFFlF8DJlMsptlZrIms4X-92bdutqCTwlfvvM7J-cD4B1GZxhL-QlzShGliiDNKGHsBTjeSc1Oe3m4M3EETkpZI0SEoPg1OKJEYcKRPgY356UkF-0c0wRTgBdf25bDKz_5OTp4l4aHMeXNKpaxwB9xXsE25rxKJRZopx4u4r3PsLWT8_kNeBXsUPzbx_MUfL-8-NZ-aRa3V9ft-aJxnKi5CX2PGWKKYqocY0GToFVQQfcOBcWYZQIToQkPQXW-k07pnlvOsXSk45rQU3C95_bJrs0mx9HmB5NsNL-FlJfG5jr94A3qHFa-bgdZyoIMSjIlNBbKhl4LGSrr85612Xaj752f5myHJ9CnL1NcmWW6N5IxJAmugI-PgJx-bn2ZzRiL88NgJ5-2xRBGOadYIFmtH55Z12mbp7oqQ7hENR3FWXWhvcvlVEr24TAMRmYXunkeei15_-8nDgV_Uq6GZm8odun_dv0v8BcIcrHO</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Yang, Gang</creator><creator>Yang, Yuxia</creator><creator>Ma, Xin</creator><creator>Huang, Lijun</creator><creator>Li, Wenbin</creator><creator>Song, Xuejuan</creator><creator>Zhang, Huiqin</creator><creator>Liu, Wenwen</creator><creator>Lu, Juanjuan</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8446-6382</orcidid></search><sort><creationdate>2020</creationdate><title>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</title><author>Yang, Gang ; Yang, Yuxia ; Ma, Xin ; Huang, Lijun ; Li, Wenbin ; Song, Xuejuan ; Zhang, Huiqin ; Liu, Wenwen ; Lu, Juanjuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Cirrhosis</topic><topic>Gene polymorphism</topic><topic>Genotype &amp; phenotype</topic><topic>Genotyping</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Gang</creatorcontrib><creatorcontrib>Yang, Yuxia</creatorcontrib><creatorcontrib>Ma, Xin</creatorcontrib><creatorcontrib>Huang, Lijun</creatorcontrib><creatorcontrib>Li, Wenbin</creatorcontrib><creatorcontrib>Song, Xuejuan</creatorcontrib><creatorcontrib>Zhang, Huiqin</creatorcontrib><creatorcontrib>Liu, Wenwen</creatorcontrib><creatorcontrib>Lu, Juanjuan</creatorcontrib><collection>SAGE Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Technology in cancer research &amp; treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Gang</au><au>Yang, Yuxia</au><au>Ma, Xin</au><au>Huang, Lijun</au><au>Li, Wenbin</au><au>Song, Xuejuan</au><au>Zhang, Huiqin</au><au>Liu, Wenwen</au><au>Lu, Juanjuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer</atitle><jtitle>Technology in cancer research &amp; treatment</jtitle><addtitle>Technol Cancer Res Treat</addtitle><date>2020</date><risdate>2020</risdate><volume>19</volume><spage>1533033820943244</spage><epage>1533033820943244</epage><pages>1533033820943244-1533033820943244</pages><issn>1533-0346</issn><eissn>1533-0338</eissn><abstract>Introduction: To explore association of excision repair cross-complementing 5 (ERCC5) genetic polymorphisms with cirrhosis and liver cancer. Methods: A total of 365 patients were enrolled, including control group (n = 133), cirrhosis group (n = 122), and liver cancer group (n = 110). The genotyping of ERCC5 rs2016073, rs751402, rs2094258, rs2296147, and rs2296148 was measured by using MassARRAY iPLEX technology. Results: There were no significant differences in gender and drinking among the 3 groups (P &gt; .05). There were significant differences among the 3 groups in both age-group ≤60 and &gt;60 subgroup patients. Locus rs2016073 was significantly different among 3 groups, and genotype GG (n = 0) was not observed in liver cancer group. As for locus rs751402, there were significant differences among 3 groups, and genotype AA (n = 0) was not observed in liver cancer group. As for locus rs2094258, there were no significant differences among 3 groups. Locus rs2296147 showed no significant differences among 3 groups (P &gt; .05), but genotype CC was not observed in liver cancer group (n = 0). As for locus rs2296148, there were significant differences among 3 groups, and genotype TC (n = 0) was not observed in cirrhosis group. Regression analysis found locus rs751402 had significant difference between control group and cirrhosis group, patients with genotype AA and genotype GG were more likely to have cirrhosis than those with genotype GA. Conclusion: Our study suggested that genotype AA, genotype GG of ERCC5 locus rs751402, and genotype TC of locus rs2296148 may be important targets for cirrhosis, while ERCC5 polymorphisms (rs2016073 and ERCC5 polymorphisms, rs2016073 with genotype GG, and rs751402 with genotype AA) may be potential markers for liver cancer.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>32812509</pmid><doi>10.1177/1533033820943244</doi><orcidid>https://orcid.org/0000-0001-8446-6382</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1533-0346
ispartof Technology in cancer research & treatment, 2020, Vol.19, p.1533033820943244-1533033820943244
issn 1533-0346
1533-0338
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_0bc18e2090a34f7f874869168afd967f
source Open Access: PubMed Central; SAGE Open Access; Publicly Available Content (ProQuest)
subjects Age
Cirrhosis
Gene polymorphism
Genotype & phenotype
Genotyping
Liver cancer
Liver cirrhosis
Original
title Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T04%3A43%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20ERCC5%20Genetic%20Polymorphisms%20With%20Cirrhosis%20and%20Liver%20Cancer&rft.jtitle=Technology%20in%20cancer%20research%20&%20treatment&rft.au=Yang,%20Gang&rft.date=2020&rft.volume=19&rft.spage=1533033820943244&rft.epage=1533033820943244&rft.pages=1533033820943244-1533033820943244&rft.issn=1533-0346&rft.eissn=1533-0338&rft_id=info:doi/10.1177/1533033820943244&rft_dat=%3Cproquest_doaj_%3E2435531607%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c528t-fdd140483138c44f92f98f8f9dc0f844a46126925ff8beb7c89d5a5517c2b5923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2570002854&rft_id=info:pmid/32812509&rft_sage_id=10.1177_1533033820943244&rfr_iscdi=true